Newsletter Archive

Newsroom

Voice of America Logo

GPZL Secretariat Director discusses leprosy prevalence and prevention on Voice of America

2 March, 2021 | Global Partnership for Zero Leprosy

GPZL Secretariat Director, Bill Gallo, sat down with Linord Moudou, host of Voice of America’s Healthy Living series, to discuss leprosy prevalence and the new path toward prevention. The segment, “Fear and Loathing of Leprosy,” opens with perspectives of persons affected … More GPZL Secretariat Director discusses leprosy prevalence and prevention on Voice of America

Read Article >
Young girl in Nepal receives preventive treatment (SDR-PEP) for leprosy

New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years

2 March, 2021 | NLR International

To interrupt leprosy transmission and reduce annual new cases significantly, contact tracing and preventive treatment needs to be implemented in all leprosy-endemic countries Amsterdam, the Netherlands, March 1, 2021 – New research by NLR, until No Leprosy Remains (NLR) and Erasmus University … More New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years

Read Article >
Sasakawa Leprosy Initiative

“Right to Work” Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy

29 January, 2021 | Sasakawa Leprosy Initiative

TOKYO/BRUSSELS, January 28, 2021 – The 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy will be launched in an online ceremony on January 31, 2021, World Leprosy Day. Organized by Sasakawa Leprosy (Hansen’s Disease) Initiative, this year’s … More “Right to Work” Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy

Go to Article >

Women affected by leprosy speak out about COVID-19 challenges

14 December, 2020 | Global Partnership for Zero Leprosy

Women affected by leprosy share concerns of the community of persons affected during the COVID-19 pandemic in a video, recently released by GPZL. By learning from these women affected by leprosy, the NTD community can strengthen strategies to reach zero discrimination, zero stigma, and zero disability for persons affected by leprosy and other NTDs worldwide. And by looking to the experts on the ground, including those who have experienced NTDs, NGOs and governments can better fill in the gaps in COVID-19 response.

Read Article >
Alice Cruz Call for Questionnaire

Call for Contributions from Persons Affected by Hansen’s Disease for Report to Human Rights Council

9 December, 2020 | Alice Cruz

The Special Rapporteur on the elimination of discrimination against persons affected by Hansen’s disease and their family members, Alice Cruz, is preparing a report due to be presented at the 47th session of the Human Rights Council in June 2021. … More Call for Contributions from Persons Affected by Hansen’s Disease for Report to Human Rights Council

Read Article >
Dr Mwelecele Ntuli Malecela

Neglected Tropical Diseases: World Health Assembly endorses bold new road map targets for 2030

12 November, 2020 | World Health Organization

12 November 2020 — Today, delegates attending the virtual session of the Seventy-third World Health Assembly overwhelmingly endorsed the new road map for neglected tropical diseases (NTDs) for 2021−2030. Ending the neglect to attain the Sustainable Development Goals: a road … More Neglected Tropical Diseases: World Health Assembly endorses bold new road map targets for 2030

Read Article >
Sasakawa Grant Program

Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19

4 November, 2020 | Sasakawa Health Foundation

TOKYO, Oct. 29, 2020 — Sasakawa Leprosy (Hansen’s Disease) Initiative will launch a US$340,000 grant program on November 1 to support communities of persons affected by leprosy around the world that have been hard hit by the effects of the … More Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19

Read Article >
LPEP Novartis

Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

2 November, 2020 | Novartis International AG

Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

Read Article >